DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023

Shares 37,404 Value ($000) $1 Avg Close $25.37 Range $20.52 - $30.79

Q1 2022

Shares 6,940 Value ($000) $223 Avg Close $34.41 Range $28.76 - $47.47

Q4 2021

Shares 5,834 Value ($000) $260 Avg Close $47.38 Range $41.10 - $56.08

Q3 2021

Shares 14,892 Value ($000) $751 Avg Close $56.36 Range $47.02 - $79.50

Q1 2021

Shares 5,583 Value ($000) $319 Avg Close $66.94 Range $52.23 - $84.25

Q2 2019

Shares 25,564 Value ($000) $531 Avg Close $22.41 Range $18.28 - $28.86

Q1 2019

Shares 9,320 Value ($000) $216 Avg Close $20.92 Range $17.73 - $25.05

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2023	37,404	$1	$25.37	$20.52 - $30.79
Q1 2022	6,940	$223	$34.41	$28.76 - $47.47
Q4 2021	5,834	$260	$47.38	$41.10 - $56.08
Q3 2021	14,892	$751	$56.36	$47.02 - $79.50
Q1 2021	5,583	$319	$66.94	$52.23 - $84.25
Q2 2019	25,564	$531	$22.41	$18.28 - $28.86
Q1 2019	9,320	$216	$20.92	$17.73 - $25.05